Skip to main content
All lobbying filings

FIERCE GOVERNMENT RELATIONS

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · Trade Organization for Generic Drug Manufacturers and Distributers

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 8
  • HR 7410
    American Made Medicine Act
  • S 4327
    Securing America’s Drug Supply from Communist China Act
  • S 2658
    Medication Affordability and Patent Integrity Act
  • S 3014
    Ensuring Timely Access to Generics Act of 2025
  • S 1414
    Expedited Access to Biosimilars Act
  • S 1954
    Biosimilar Red Tape Elimination Act
  • S 3788
    CLEAR LABELS Act
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
 Lobbying activity 1
Pharmacy

H.R.7410 - American Made Medicine Act; Drug shortages; Generic drugs; Issues around country of origin labeling; S.4327 - Securing America's Drug Supply from Communist China Act; S.2658 - Medication Affordability and Patent Integrity Act; S.3014 - Ensuring Timely Access to Generics Act; S.1414 - Expedited Access to Biosimilars Act; S.1954 - Biosimilar Red Tape Reduction Act; S.3788 - Clear Labels Act; S.4784 - Fiscal Year 2027 National Defense Authorization Act; Supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem